Cited 0 times in

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01)

DC Field Value Language
dc.contributor.author정현철-
dc.date.accessioned2023-06-02T01:16:56Z-
dc.date.available2023-06-02T01:16:56Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194785-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleTrastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKensei Yamaguchi-
dc.contributor.googleauthorYung-Jue Bang-
dc.contributor.googleauthorSatoru Iwasa-
dc.contributor.googleauthorNaotoshi Sugimoto-
dc.contributor.googleauthorMin-Hee Ryu-
dc.contributor.googleauthorDaisuke Sakai-
dc.contributor.googleauthorHyun Cheol Cheol Chung-
dc.contributor.googleauthorHisato Kawakami-
dc.contributor.googleauthorHiroshi Yabusaki-
dc.contributor.googleauthorJeeyun Lee-
dc.contributor.googleauthorKaku Saito-
dc.contributor.googleauthorYoshinori Kawaguchi-
dc.contributor.googleauthorTakahiro Kamio-
dc.contributor.googleauthorAkihito Kojima-
dc.contributor.googleauthorMasahiro Sugihara-
dc.contributor.googleauthorKohei Shitara-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.242-
dc.contributor.localIdA03773-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.242-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.affiliatedAuthor정현철-
dc.citation.volume40-
dc.citation.number4 suppl-
dc.citation.startPage242-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 242, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.